[Chloramphenicol concentrations in serum and CSF in newborn infants and babies with bacterial meningitis (author's transl)]
Related Experiment Videos
Insights
Chloramphenicol dosing in infants requires careful monitoring. Premature and full-term newborns exhibit significant variations in drug levels, necessitating precise administration to avoid toxicity and ensure efficacy in treating bacterial meningitis.
Area of Science:
- Pharmacology
- Pediatrics
- Infectious Diseases
Context:
- Bacterial meningitis is a serious infection in infants.
- Chloramphenicol is an antibiotic used to treat bacterial meningitis.
- Accurate drug dosing is critical for therapeutic success and patient safety in neonates and infants.
Purpose:
- To assess serum and cerebrospinal fluid (CSF) chloramphenicol concentrations in premature and full-term infants with bacterial meningitis.
- To identify factors influencing chloramphenicol levels, including dosage, patient age, and drug interactions.
- To establish safe and effective dosing guidelines for chloramphenicol in this vulnerable population.
Summary:
- Serum and CSF chloramphenicol levels were monitored in 24 infants with bacterial meningitis.
- Premature infants showed dose-related and drug-interaction-related concentration variations.
- Full-term newborns could tolerate higher doses, but small dosage changes still caused marked concentration increases, with 100 mg/kg/day only feasible after 6-8 weeks of life.
Impact:
- Highlights the critical need for individualized chloramphenicol dosing strategies in neonates and infants.
- Informs clinical practice regarding safe chloramphenicol administration in pediatric meningitis treatment.
- Emphasizes the importance of therapeutic drug monitoring to prevent adverse events and optimize treatment outcomes.
Abstract:
Serum and CSF levels of chloramphenicol were determined repeatedly during the course of treatment in 24 premature and full term babies and infants with bacterial meningitis. Variations in chloramphenicol concentrations were caused in the premature babies by a small dose increase or by interaction with other drugs. In the fullterm newborn babies a higher dose could be given but even in these children the increase in concentration after small changes in dosage was marked. Chloramphenicol doses of 100 mg/kg daily could only be given after the sixth or eighth weeks of life. In the mature newborns and in the older babies inaccuracies in the administration of the drug may be a cause of marked variations of serum and CSF concentrations.